Is miDiagnostics still active?

Yes, miDiagnostics is currently active.

Where is miDiagnostics registered?

miDiagnostics's registered address is Gaston Geenslaan 1, 3001 Leuven, Belgium.

How many employees does miDiagnostics have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), miDiagnostics reported 54.2 full-time equivalent employees.

What is miDiagnostics's annual turnover?

miDiagnostics's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €24,934.

Did miDiagnostics make a profit or a loss?

miDiagnostics's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a loss of €12,595,117.

When did miDiagnostics last file annual accounts?

miDiagnostics's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is miDiagnostics B Corp certified?

We have no B Corp certification on file for miDiagnostics.

Does miDiagnostics hold Fairtrade certification?

No, miDiagnostics does not currently hold Fairtrade certification.

miDiagnostics

Q: When was miDiagnostics founded?

miDiagnostics was founded on 28 Oct 2015, making it 10 years old.

Q: What does miDiagnostics do?

miDiagnostics's registered main activities are Business and other management consultancy activities, Research and experimental development on other natural sciences and engineering, Diagnostic imaging services and medical laboratory activities, Research and experimental development on biotechnology, Office administrative and support activities, and Manufacture of other pharmaceutical products.

BE 0641.984.602

Copied!

NV/SA

Status

Active

Founded

28 Oct 2015

Size

Medium · 54.2 FTE

Age

10 yrs

Main activity

Business and other management consultancy activities

Activities

6 activities

Business and other management consultancy activitiesResearch and experimental development on other natural sciences and engineeringDiagnostic imaging services and medical laboratory activitiesResearch and experimental development on biotechnologyOffice administrative and support activitiesManufacture of other pharmaceutical products

Financials

Turnover2025

€24.9K+72.4%

Profit / Loss2025

−€12.6M+32.2%

Equity2025

−€10.6M-631.5%

2025	2024	2023	2022
€24,934+72.4%	€14,467+118.2%	€6,629-97.4%	€252,716
-€12,595,117+32.2%	-€18,572,530+21.4%	-€23,616,802+14.2%	-€27,526,312
-€10,600,721-631.5%	€1,994,397+251.8%	€566,927-96%	€14,063,728
€22,204,084-11.8%	€25,186,053+1.7%	€24,763,295+50.8%	€16,426,135
€652,998-92.6%	€8,872,121>1000%	€536,620-85.7%	€3,749,372
54.2-21%	68.6-7.2%	73.9-20.4%	92.8
€460+118.1%	€211+135.1%	€90-96.7%	€2,723

Frequently asked questions

01What is miDiagnostics's official registered name?

miDiagnostics.

02What is miDiagnostics's enterprise number (VAT number)?

BE 0641.984.602.

03What is miDiagnostics's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was miDiagnostics founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€24,934+72.4%	€14,467+118.2%	€6,629-97.4%	€252,716
	€5,599,732-13.3%	€6,457,445-13%	€7,422,512-12.7%	€8,505,384
	-€13,164,140+29.2%	-€18,600,452+23.2%	-€24,231,075+13.5%	-€28,021,646
	€6,918,710>1000%	€405,005+109.7%	-€4,162,035	—
	-€12,595,117+32.2%	-€18,572,530+21.4%	-€23,616,802+14.2%	-€27,526,312
	€96,081-88.4%	€831,180+410.2%	€162,914+12.5%	€144,852
Profitability
	27747.6%+891.2%	2799.5%+104.5%	-62785.3%	—
	-50512.9%+60.7%	-128377.8%+64%	-356264.9%<-1000%	-10892.2%
	118.8%+112.8%	-931.2%+77.7%	-4165.8%<-1000%	-195.7%
	-108.5%-58.9%	-68.3%+26.7%	-93.2%-3.3%	-90.3%
Solvency
	€11,603,363-57.3%	€27,180,449+7.3%	€25,330,221-16.9%	€30,489,863
	€1,655,672-57.9%	€3,932,394-7.3%	€4,240,597+15.1%	€3,684,617
	€0-100%	€6,5000%	€6,500-22.2%	€8,360
	-€10,600,721-631.5%	€1,994,397+251.8%	€566,927-96%	€14,063,728
	-91.4%<-1000%	7.3%+227.8%	2.2%-95.1%	46.1%
	€16,000,0000%	€16,000,0000%	€16,000,000+45.1%	€11,025,221
	-1.51-118.8%	8.02-71.6%	28.22>1000%	0.78
	€22,204,084-11.8%	€25,186,053+1.7%	€24,763,295+50.8%	€16,426,135
	-2.09-116.6%	12.63-71.1%	43.68>1000%	1.17
	-123.25-337.5%	-28.17+65.8%	-82.45+75.3%	-333.92
Liquidity
	€652,998-92.6%	€8,872,121>1000%	€536,620-85.7%	€3,749,372
	€32,782-98.1%	€1,775,239-25.8%	€2,392,650-38.8%	€3,910,672
	€110,663-90.2%	€1,132,846-48.6%	€2,202,933+867.2%	€227,757
	€2,591,510+18%	€2,195,929-8.8%	€2,408,209-40.2%	€4,027,399
	€5,932,862+58.5%	€3,743,514-41.2%	€6,368,344+18.8%	€5,359,247
	0.31-26.5%	0.42-45.3%	0.76-34.4%	1.16
	-€3,648,794-203.6%	€3,520,429+329.5%	-€1,534,012-133.1%	€4,639,437
Efficiency
	1620 days-94.3%	28581 days-76.4%	121296 days>1000%	329 days
	66 days+56%	42 days-24.9%	56 days-30.1%	81 days
	2 days-98%	101 days-46.5%	188 days-42.6%	328 days
	6.59+113.3%	3.09+110.2%	1.47-34.1%	2.23
Profit appropriation
	-€12,595,117+32.2%	-€18,572,530+21.4%	-€23,616,802+47.8%	-€45,229,541

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€24,934+72.4%	€14,467+118.2%	€6,629-97.4%	€252,716
	€5,599,732-13.3%	€6,457,445-13%	€7,422,512-12.7%	€8,505,384
	-€13,164,140+29.2%	-€18,600,452+23.2%	-€24,231,075+13.5%	-€28,021,646
	€6,918,710>1000%	€405,005+109.7%	-€4,162,035	—
	-€12,595,117+32.2%	-€18,572,530+21.4%	-€23,616,802+14.2%	-€27,526,312
	€96,081-88.4%	€831,180+410.2%	€162,914+12.5%	€144,852
Profitability
	27747.6%+891.2%	2799.5%+104.5%	-62785.3%	—
	-50512.9%+60.7%	-128377.8%+64%	-356264.9%<-1000%	-10892.2%
	118.8%+112.8%	-931.2%+77.7%	-4165.8%<-1000%	-195.7%
	-108.5%-58.9%	-68.3%+26.7%	-93.2%-3.3%	-90.3%
Solvency
	€11,603,363-57.3%	€27,180,449+7.3%	€25,330,221-16.9%	€30,489,863
	€1,655,672-57.9%	€3,932,394-7.3%	€4,240,597+15.1%	€3,684,617
	€0-100%	€6,5000%	€6,500-22.2%	€8,360
	-€10,600,721-631.5%	€1,994,397+251.8%	€566,927-96%	€14,063,728
	-91.4%<-1000%	7.3%+227.8%	2.2%-95.1%	46.1%
	€16,000,0000%	€16,000,0000%	€16,000,000+45.1%	€11,025,221
	-1.51-118.8%	8.02-71.6%	28.22>1000%	0.78
	€22,204,084-11.8%	€25,186,053+1.7%	€24,763,295+50.8%	€16,426,135
	-2.09-116.6%	12.63-71.1%	43.68>1000%	1.17
	-123.25-337.5%	-28.17+65.8%	-82.45+75.3%	-333.92
Liquidity
	€652,998-92.6%	€8,872,121>1000%	€536,620-85.7%	€3,749,372
	€32,782-98.1%	€1,775,239-25.8%	€2,392,650-38.8%	€3,910,672
	€110,663-90.2%	€1,132,846-48.6%	€2,202,933+867.2%	€227,757
	€2,591,510+18%	€2,195,929-8.8%	€2,408,209-40.2%	€4,027,399
	€5,932,862+58.5%	€3,743,514-41.2%	€6,368,344+18.8%	€5,359,247
	0.31-26.5%	0.42-45.3%	0.76-34.4%	1.16
	-€3,648,794-203.6%	€3,520,429+329.5%	-€1,534,012-133.1%	€4,639,437
Efficiency
	1620 days-94.3%	28581 days-76.4%	121296 days>1000%	329 days
	66 days+56%	42 days-24.9%	56 days-30.1%	81 days
	2 days-98%	101 days-46.5%	188 days-42.6%	328 days
	6.59+113.3%	3.09+110.2%	1.47-34.1%	2.23
Profit appropriation
	-€12,595,117+32.2%	-€18,572,530+21.4%	-€23,616,802+47.8%	-€45,229,541

2025

2024

2023

2022

Income statement

€24,934+72.4%

€14,467+118.2%

€6,629-97.4%

€252,716

€5,599,732-13.3%

€6,457,445-13%

€7,422,512-12.7%

€8,505,384

-€13,164,140+29.2%

-€18,600,452+23.2%

-€24,231,075+13.5%

-€28,021,646

€6,918,710>1000%

€405,005+109.7%

-€4,162,035

—

-€12,595,117+32.2%

-€18,572,530+21.4%

-€23,616,802+14.2%

-€27,526,312

€96,081-88.4%

€831,180+410.2%

€162,914+12.5%

€144,852

Profitability

27747.6%+891.2%

2799.5%+104.5%

-62785.3%

—

-50512.9%+60.7%

-128377.8%+64%

-356264.9%<-1000%

-10892.2%

118.8%+112.8%

-931.2%+77.7%

-4165.8%<-1000%

-195.7%

-108.5%-58.9%

-68.3%+26.7%

-93.2%-3.3%

-90.3%

Solvency

€11,603,363-57.3%

€27,180,449+7.3%

€25,330,221-16.9%

€30,489,863

€1,655,672-57.9%

€3,932,394-7.3%

€4,240,597+15.1%

€3,684,617

€0-100%

€6,5000%

€6,500-22.2%

€8,360

-€10,600,721-631.5%

€1,994,397+251.8%

€566,927-96%

€14,063,728

-91.4%<-1000%

7.3%+227.8%

2.2%-95.1%

46.1%

€16,000,0000%

€16,000,000+45.1%

€11,025,221

-1.51-118.8%

8.02-71.6%

28.22>1000%

0.78

€22,204,084-11.8%

€25,186,053+1.7%

€24,763,295+50.8%

€16,426,135

-2.09-116.6%

12.63-71.1%

43.68>1000%

1.17

-123.25-337.5%

-28.17+65.8%

-82.45+75.3%

-333.92

Liquidity

€652,998-92.6%

€8,872,121>1000%

€536,620-85.7%

€3,749,372

€32,782-98.1%

€1,775,239-25.8%

€2,392,650-38.8%

€3,910,672

€110,663-90.2%

€1,132,846-48.6%

€2,202,933+867.2%

€227,757

€2,591,510+18%

€2,195,929-8.8%

€2,408,209-40.2%

€4,027,399

€5,932,862+58.5%

€3,743,514-41.2%

€6,368,344+18.8%

€5,359,247

0.31-26.5%

0.42-45.3%

0.76-34.4%

1.16

-€3,648,794-203.6%

€3,520,429+329.5%

-€1,534,012-133.1%

€4,639,437

Efficiency

1620 days-94.3%

28581 days-76.4%

121296 days>1000%

329 days

66 days+56%

42 days-24.9%

56 days-30.1%

81 days

2 days-98%

101 days-46.5%

188 days-42.6%

328 days

6.59+113.3%

3.09+110.2%

1.47-34.1%

2.23

Profit appropriation